SCHEMBL31496233

SCHEMBL31496233

Cc1cc2c(Br)cc(OC3CCN(C(=O)OC(C)(C)C)CC3)cc2n(C)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 6/20 0.46
▸ NPBWR1 P48145 1/20 0.44
▸ MCHR1 Q99705 1/20 0.44
▸ PDE4A P27815 2/20 0.43
▸ PDE4B Q07343 2/20 0.43
▸ PDE4C Q08493 2/20 0.43
▸ PDE4D Q08499 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ PRKDC P78527 1/20 0.40
▸ SGMS1 Q86VZ5 1/20 0.40
▸ SGMS2 Q8NHU3 1/20 0.40
▸ P2RX3 P56373 1/20 0.40
▸ P2RX2 Q9UBL9 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.40
▸ CHEK2 O96017 1/20 0.40
▸ PIK3CD O00329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26547722 0.80 GPR4 (0.42) GPR119SGMS1SGMS2
SCHEMBL848331 0.76 GPR119 (0.57) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL18918020 0.75 GPR119 (0.57) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL1892356 0.75 GPR119 (0.52) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL31425931 0.75 PDE4B (0.48) GPR119NPBWR1MCHR1PDE4APDE4B
SCHEMBL31542308 0.74 KDM4E (0.47) GPR119PDE4BKDM4EMAPTTHRB
SCHEMBL25393588 0.74 GPR119 (0.62) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL18927006 0.74 MEN1 (0.53) GPR119NPBWR1MCHR1PDE4APDE4B
SCHEMBL21606918 0.73 GPR119 (0.55) GPR119NPBWR1MCHR1PDE4APDE4B
SCHEMBL5459344 0.73 GPR119 (0.56) GPR119NPBWR1MCHR1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250136578-A1 BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS KOLM THERAPEUTICS INC. 2025-05-01 — — US disclosed
WO-2025081092-A1 BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS KOLM THERAPEUTICS INC. (US) 2025-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250136578-A1 BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS AR, SHBG, FSHR GPR119 245/4885NPBWR1 2194/4885MCHR1 576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback